All In Biotech

Drug Trial Radar · NCT07811726

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of NT-101 Topical Ophthalmic Solution in Patients With Wet Age-Related Macular Degeneration (AMD)

Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Jun 11, 2026

Primary completion

Feb 28, 2028

Study completion Mar 31, 2028

Sponsor

Lead sponsor
NexThera Co., Ltd.Industry
Sponsor type
Industry
First posted
Sep 10, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 2 trial is a randomized, double-blind, placebo-controlled, multicenter study in patients with wet AMD to assess the efficacy and safety of NT-101 topical ophthalmic solution (0.20 mM) administered into the study eye twice daily (BID) for 12 weeks.

Conditions

  • Wet Age Related Macular Degeneration

Interventions

  • NT-101 ophthalmic solutionDrug

    NT-101 is a topical ophthalmic solution containing pigment epithelium-derived factor (PEDF) 34 and type I atelocollagen

  • PlaceboDrug

    NT-101 without Drug Substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Early Treatment Diabetic Retinopathy Study (ETDRS) BCVA in the study eye at Week 12 compared to baselineTime frame: Week 12 compared to baseline

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Advanced Retina Institute

    Bonita Springs, Florida · Recruiting

  • Tulsa Retina Consultants

    Tulsa, Oklahoma · Recruiting

  • Erie Retina Research

    Erie, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.